MedTrace Logo

Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging

NCT02767609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2019-04-30

Study results available
· View outcomes & findings →

Summary

This study will test a new MRI sequence that measures cerebral blood flow (CBF). Because this technique for measuring CBF is new, there is little information on what the normal values for different regions of the brain should be. Information from the study will be used to establish normative CBF values for the brain, improving the reliable use of this technique for the diagnosis of brain injury or disease.

Conditions

Interventions

DEVICE

Magnetic Resonance Imaging

All participants will have be given a MRI using a pseudo-continuous arterial spin labeling perfusion sequence.

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Brenda Bartnik Olson, PhD · Loma Linda University Medical Center

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-03-03
Completion
2017-03-03

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02767609 on ClinicalTrials.gov